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Yerba mate aqueous extract improves the
oxidative and inﬂammatory states of rats with
adjuvant-induced arthritis
Vanesa Gesser Correa,a Anacharis B. de Sá-Nakanishi,b
Geferson de Almeida Gonçalves,a Lillian Barros, c Isabel C. F. R. Ferreira, c
Adelar Bracht a and Rosane M. Peralta *a,b
Healthy and adjuvant-induced arthritic rats were treated for 23 days with daily doses of 400 and 800 mg
kg−1 Ilex paraguariensis extract. This treatment (a) diminished the ROS levels in the liver and brain, (b)
decreased oxidative protein and lipid damage in liver and brain, (c) increased the plasma antioxidant
capacity, (d) increased the GSH levels and the GSH/GSSH ratio in both the liver and the brain, (e) almost
restored the enzymatic activities linked to the metabolism of GSH–GSSG, and (f ) reversed the modiﬁed
activities of xanthine oxidase, superoxide dismutase and catalase. The anti-inﬂammatory actions (ﬁrstly)
and the antioxidant actions (in the second place) of the yerba mate constituents (e.g., chlorogenic acid
derivatives) are the causes of these beneﬁcial eﬀects. Daily ingestion of traditional yerba mate beverages
may be eﬀective in attenuating the symptoms of inﬂammatory diseases, especially in older adults.
Introduction
Yerba mate or mate (Ilex paraguariensis A. St. Hil.) is a plant
that grows naturally in Paraguay, Uruguay, Argentina and
Brazil. Dried leaves of this plant are used to make several
kinds of beverages that are traditionally consumed in those
countries. Basically, three kinds of beverages can be prepared:
a hot water infusion of green dried leaves (which is called
“chimarrão” in Brazil), the corresponding cold water infusion
(known as “tererê”) and an infusion prepared with roasted
leaves (usually known as mate tea). The traditional habit of
consuming yerba mate infusions has probably been motivated
by their stimulating eﬀects, which are now largely attributed to
their methylxanthine constituents, namely caﬀeine, theobro-
mine and theophylline.1,2 However, during the last 20 years or
so a considerable number of studies have shown that yerba
mate possesses marked antioxidant, anti-inflammatory, vaso-
dilating, lipid reduction and weight reduction properties and
that it exerts anti-mutagenic, anti-glycation and anti-diabetic
eﬀects.1–3 This set of variable eﬀects is probably related to the
fact that, besides the xanthines, yerba mate displays a complex
chemical composition with compounds belonging to several
classes. An investigation of our research group, in which the
compositions of the leaves, stems and whole plant of yerba
mate were characterized, revealed at least five sugars, five
organic acids, eighteen fatty acids, one tocopherol, nine hydro-
xycinnamoyl derivatives (phenolic acids) and two flavonols.4
The leaf extract revealed the highest antioxidant activity, corre-
lating with its highest levels of phenolic compounds. The stem
extracts, however, presented the highest anti-inflammatory
potential as inferred from its NO production inhibitory activity
and the highest cytotoxic properties. Additionally, yerba mate
also contains vitamins (A, B complex, C and E) and tannins
and triterpenic saponins.1,2 It is not certain if all these sub-
stances are absorbed when yerba mate infusions are consumed
because digestion and fermentation in the gastrointestinal
tract could eventually cause substantial modifications. A
recent study of our group, in which yerba mate extracts were
submitted to in vitro digestion coupled to colonic fermenta-
tion, allows to infer about the gastrointestinal events prior to
the absorption of the phenolic compounds that are listed in
Table 1.5 Digestion and fermentation in the gastrointestinal
tract apparently causes pronounced decreases in the 3,5-O-
dicaﬀeoylquinic and 5-O-caﬀeoylquinic acid (chlorogenic acid)
contents. Other compounds, however, such as 3-O-caﬀeoyl-
quinic acid (neochlorogenic acid), 4-O-caﬀeoylquinic acid (crypto-
chlorogenic acid) and salvianolic acid I are only minimally
aﬀected. This corroborates the general notion that the func-
tional properties of the yerba mate constituents are largely
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maintained after digestion in the intestinal tract.5 However,
after absorption, many transformations occur in the tissues,
including hydrolysis by esterases which produces caﬀeic and
quinic acids, O-methylation that leads to the production of
ferulic acid derivatives and conjugations to glucuronic acid
and sulfate.6,7
Among the functional properties of yerba mate, the com-
bined antioxidant and anti-inflammatory actions could be
useful in attenuating the symptoms of diseases in which
inflammation and oxidative stress are both prominent. One
such disease is rheumatoid arthritis, which is characterized by
a chronic inflammation that primarily aﬀects the small joints
of hands and feet. The disease involves well known immuno-
logical events, such as participation of T cells, B cells, macro-
phages and pro-inflammatory cytokines, and, in their pro-
gression, an increased oxidative stress in the lesion sites.8 In
addition to aﬀecting the articular cartilage, rheumatoid arthri-
tis also evokes marked inflammatory responses and oxidative
stress in other organs, such as vascular tissue, liver, brain and
the heart.9–12 In principle, the pronounced antioxidant activity
of yerba mate should be able to attenuate the oxidative stress
caused by rheumatoid arthritis.4,5 Similarly, yerba mate should
equally be able to attenuate the inflammatory state if one takes
into account its well documented anti-inflammatory
activity.13–15 Considering the antioxidant and anti-inflamma-
tory properties of yerba mate, we decided to investigate the
eﬀects of a hot water aqueous extract on both the oxidative
and inflammatory states of rats with arthritis induced by the
complete Freund’s adjuvant as a continuation of our previous
investigations on the chemical composition of hot and cold
water extracts of this plant.4,5 The hot water extract corres-
ponds to the traditional beverage known as “chimarrão” in
Brazil and simply “mate” in Spanish speaking countries.
Adjuvant-induced arthritis is an experimental immuno-pathol-
ogy in rats that shares many features of human rheumatoid
arthritis and is often used as a model for this disease.10,16,17
The study aims at providing information about the possible
benefits of the continuous and regular ingestion of yerba mate
infusions by individuals suﬀering from or predisposed to
rheumatoid arthritis.
Materials and methods
Chemicals
Dinitrophenylhydrazine (DNPH), 2′7′-dichloro-fluorescein
diacetate (DCFA-DA), oxidized dichloro-fluorescein (DCF),
1,1′,3,3′-tetraethoxy-propane, horse-radish peroxidase (HRP),
o-phthalaldehyde (OPT), reduced glutathione (GSH), oxidized
glutathione (GSSG), glutathione reductase, 6-hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid (Trolox) and Freund’s
adjuvant were purchased from Sigma-Aldrich (St Louis, MO,
USA). The commercial kit for the albumin assay was purchased
from Gold Analisa Diagnostica Ltda (Belo Horizonte, Brazil).
Water was treated in a Milli-Q water purification system (TGI
Pure Water Systems, Greenville, SC, USA). All other chemicals
were of analytical grade.
Preparation of the Ilex paraguariensis extract
Raw yerba mate was obtained from a reliable commercial
source and producer in Southern Brazil. The extract was pre-
pared in the same way as the traditional beverage
(“chimarrão”) in Brazil. For preparing, 1.5 L of water at 80 °C
was added to 85 g of yerba mate. After 5 min, the mixture was
filtered using a vacuum pump. The extract was lyophilized and
kept at −20 °C until use. Characterization of the extract in
terms of its composition in phenolic bioactives was done in a
previously published work.5 As detailed in the next sub-
section, extract doses of 400 and 800 mg kg−1 were adminis-
tered daily to healthy and arthritic rats. Table 1 presents a list
of the corresponding daily doses of phenolic bioactives, recal-
culated from the data obtained in our previous work.5
Animals and treatment
Male Holtzman rats were fed ad libitum with a standard labora-
tory diet (Nuvilab, Colombo, Brazil) maintained under stan-
dard laboratory conditions at a temperature of 24 ± 3 °C under
a regulated 12 h light/dark cycle. For the induction of arthritis,
animals weighing 180–210 g were injected in the left hind paw
with 0.1 mL (500 μg) of Freund’s complete adjuvant (heat-inac-
tivated Mycobacterium tuberculosis, derived from the human
strain H37Rv), suspended in mineral oil at a concentration of
0.5% (w/v).17 Rats of similar weights were injected with the
mineral oil and served as controls. All procedures were pre-
viously approved by the Ethics Committee for Animal
Experimentation of the State University of Maringá (Protocol
no. 6168170117).
The animals were divided into 7 groups: (1) group C were
healthy animals (controls); (2) group C-T 400 were healthy
animals treated with 400 mg kg−1 Ilex paraguariensis (yerba
mate) extract; (3) group C-T 800 were healthy animals treated
with 800 mg kg−1 yerba mate extract; (4) group AIA were the
arthritic rats; (5) group AIA-T 400 comprised the arthritic rats
treated with 400 mg kg−1 yerba mate extract; (6) group AIA-T
800 comprised the arthritic rats treated with 800 mg kg−1
yerba mate extract; and (7) group AIA-ibuprofen were arthritic
rats treated with ibuprofen (35 mg kg−1, positive controls).
Table 1 Daily doses of phenolic compounds administered to the
control and arthritic rats, recalculated from the corresponding contents
of the yerba mate aqueous extract reported in a previous work5
Compound
Daily dose of each compound (mg kg−1)
400 mg kg−1 dose 800 mg kg−1 dose
3-O-Caﬀeoylquinic acid 5.12 10.24
4-O-Caﬀeoylquinic acid 5.55 11.10
5-O-Caﬀeoylquinic acid 8.37 16.74
Caﬀeic acid hexoside 0.23 0.46
Caﬀeic acid derivative 1.43 2.86
3,4-O-Dicaﬀeoylquinic acid 1.84 3.68
3,5-O-Dicaﬀeoylquinic acid 7.74 15.48
4,5-O-Dicaﬀeoylquinic acid 2.58 5.16
Quercetin 3-O-rutinoside 2.24 4.48
Salvianolic acid 11.78 23.56
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For each treatment, the rats received the extract or ibupro-
fen once a day by oral administration (gavage) for 5 days prior
to the induction of arthritis and for additional 18 days after
initiating the induction. The treated controls received the
same doses for 23 days. Non-treated animals, healthy or
arthritic, received water for 23 days.
Blood collection and tissue preparation
Rats fasted for 18 hours were anesthetized by intraperitoneal
injection of sodium thiopental (100 mg kg−1) plus lidocaine
(10 mg kg−1). After exposition of the peritoneal cavity by lapar-
otomy, blood was collected from the cava vein and poured into
tubes containing an anticoagulant (100 IU mL−1 of sodium
heparin). Subsequently, the samples were centrifuged at 1000g
for 10 min for separating the plasma fraction.18
After blood collection, the brain and the liver were immedi-
ately removed, freeze-clamped, and stored in liquid nitrogen.
Subsequently, the tissues were homogenized separately in a
van Potter homogenizer with 10 volumes of ice-cold 0.1 M pot-
assium phosphate buﬀer (pH 7.4) and aliquots were separated
for use as total homogenates. The remaining fractions were
centrifuged at 11 000g for 15 min, and the supernatants separ-
ated as the soluble fractions of the homogenates.18
Protein concentration was measured with the Folin–
Ciocalteu reagent, using bovine serum–albumin as a
standard.19
Oxidative state indicators and antioxidant capacity
Levels of ROS were quantified in the supernatants of the
homogenates by spectrofluorimetry using 2′,7′-dichlorofluores-
cein diacetate (DCFH-DA).20 A standard curve with oxidized
dichlorofluorescein (DCF) was used to express the results as
nmol mg−1 protein.18
Reduced glutathione (GSH) and oxidized glutathione
(GSSG) levels were measured in the total homogenate. Both
analyses were done spectrofluorimetrically (excitation at
350 nm and emission at 420 nm) by means of the o-phthal-
aldehyde (OPT) assay, as described previously.21 Fluorescence
was estimated as GSH. For the GSSG assay, the sample was pre-
viously incubated with 10 mM N-ethylmaleimide and sub-
sequently with a mixture containing 1 M NaOH and 0.4 µM
OPT to detect the fluorescence. Standard curves were prepared
with GSH or GSSG, and the contents were expressed as nmol
mg−1 protein.
Enzymatic activities
Enzymatic activities were assessed in the homogenate super-
natant. The catalase (CAT) activity was estimated by measuring
changes in absorbance at 240 nm using H2O2 as the substrate
and expressed as µmol min−1 (mg protein)−1.22 The gluta-
thione reductase (GR) activity was estimated by measuring
changes in absorbance at 340 nm using NADPH and GSSG as
substrates and expressed as nmol min−1 (mg protein)−1.22 The
superoxide dismutase (SOD) activity was estimated by its
capacity to inhibit the pyrogallol auto-oxidation in an alkaline
medium. The latter was measured spectrophotometrically at
420 nm.23 One SOD unit was considered the quantity of
enzyme that was able to promote 50% inhibition, and the
results were expressed as units per mg protein. The gluta-
thione peroxidase (GPx) activity was estimated by measuring
changes in absorbance at 340 nm due to NADPH oxidation in
the presence of H2O2, GSH and glutathione reductase and
expressed as nmol min−1 (mg protein)−1.24 The xanthine
oxidase (XO) activity was measured as the increase in absor-
bance at 295 nm due to uric acid formation, and the rates were
expressed as nmol min−1 (mg protein)−1.25
The myeloperoxidase activity (MPO) was determined by the
o-dianisidine dihydrochloride–H2O2 method.
26 The change in
absorbance at 460 nm was measured for 1 minute. The activity
was calculated from the molar extinction coeﬃcient (ε = 1.13 ×
104 M−1 cm−1), and the activities were expressed as nmol
min−1 (mg protein)−1.
Oxidative injury parameters
The TBARS (thiobarbituric acid reactive substances) method
was used to evaluate lipid peroxidation by oxidative damage. A
standard curve, prepared with 1′,3,3′-tetraethoxypropane, was
used to evaluate the number of lipoperoxides, and the values
were expressed as nmol mg−1 protein.27 Protein carbonyls were
measured in plasma and in liver and brain homogenates using
2,4-dinitrophenylhydrazine (DNPH) (ε370 = 2.2 × 10
4 M−1
cm−1), and the values were expressed as nmol mg−1 protein for
the plasma and nmol mg−1 protein for the liver and brain.28
Plasma redox and liver and kidney damage indicators
The antioxidant capacity of the plasma was estimated as the
ferric ion antioxidant reducing power (FRAP) by spectro-
photometry.29 The standard curve was prepared with Trolox
(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid), and
the activity was expressed as mmol of Trolox equivalents per
mL of plasma.
Albumin, protein, aspartate aminotransferase (AST) activity
and alanine aminotransferase (ALT) activity were measured in
the plasma using commercial kits (Gold Analisa®). Globulin
levels were calculated as the diﬀerence between the total
protein and albumin concentrations.
Leukocytes, secondary lesions and paw volume
The inflammatory response induced by Freund’s complete
adjuvant was inferred from the number of leukocytes in the
femorotibial joint cavities of the legs, the secondary lesion
score and the paw volume.18 The determination of the number
of leukocytes recruited in the femorotibial joint cavities of the
legs (injected and not injected) of the arthritic rats was done
on day 18 after the induction of arthritis. Evaluation of the sec-
ondary lesions scores (in the ears, front legs and tail) was
started at the 11th day and repeated daily until the end of the
experiment on day 18. The severity of the injury was graded
from zero to 5, zero indicating no injury. The volume of the
paw was evaluated in the hind paws of the arthritic rats on
days 0, 1, 3, 5, 7, 10, 12, 14, 16 and 18 and was measured with
a plethysmograph (Ugo Basile®). The results of the paw
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volume were expressed as absolute increases in paw volume
(µL) relative to the initial volume.
Statistical analysis
The parameters presented in the graphs and tables are means
± standard errors of the means. Statistical analysis was done
using the GraphPad Prism Software (version 5.0). The statisti-
cal significance of the data was analyzed by means of one-way
ANOVA followed by Student–Newman–Keuls post-hoc testing
with the 5% significance level (p ≤ 0.05).
Results
Liver and brain oxidative stress indicators
Evaluations of the oxidative stress indicators in the liver and
brain, protein carbonyls (panels A and B), ROS levels (panels
C and D) and lipid peroxidation (panels E and F), are summar-
ized in Fig. 1. In the healthy rats, the yerba mate treatment did
not aﬀect any of the three evaluated parameters. Adjuvant-
induced arthritis, on the other hand, confirming previous
reports, clearly increased protein carbonylation, ROS levels
and lipid peroxidation in both tissues.10,12 Treatment of the
arthritic rats with the yerba mate extract diminished the
eﬀects of arthritis on the three parameters. In general terms,
the eﬀect tended to be more pronounced in the liver than in
the brain, and in general, also no diﬀerences were found for
the actions of the two doses that were employed (400 and
800 mg kg−1). In two cases, lipid peroxidation in the liver of
the arthritic rats (panel E) and ROS levels in the brain of the
arthritic rats (panel D), the yerba mate treatment diminished
the influence of arthritis to the point that the small diﬀerences
in comparison with the corresponding controls were no longer
statistically significant. Administration of ibuprofen at the
dose of 35 mg kg−1 was equally eﬀective on all parameters
tested in both tissues.
Plasma oxidative stress and inflammatory indicators
Fig. 2 illustrates the influence of arthritis and the subsequent
yerba mate treatment on oxidative stress and inflammatory
indicators in the plasma. None of the four parameters that
were investigated, namely protein carbonylation (panel A),
antioxidant capacity (FRAP, panel B), myeloperoxidase activity
(panel C) and protein thiol levels (panel D), were modified by
the yerba mate treatment in the healthy rats. Protein
carbonylation (panel A) was increased by arthritis, confirming
a previous report.18 Both doses of yerba mate diminished the
levels of carbonylated proteins, but to values that were still
clearly above those in the healthy rats. The action of ibuprofen
was also significant, but not very pronounced. The ferric ion
reducing ability (FRAP; panel B), an indicator of the anti-
oxidant capacity, was diminished by arthritis, again confirm-
ing previous reports.18 The yerba mate treatment attenuated
the influence of arthritis, the 800 mg kg−1 dose tending to be
more eﬀective than the 400 mg kg−1 dose. A similar eﬀect was
found in the ibuprofen treated arthritic rats. The marked influ-
ence of arthritis on the myeloperoxidase activity (MPO; panel
C), a 4.5-fold increase, also confirms previous reports.18
Treatment with yerba mate caused diminutions in the
increased MPO activities, the 400 mg kg−1 dose being less
eﬀective than the 800 mg kg−1 dose. However, even under
treatment with the highest dose, the arthritic rats still pre-
sented MPO levels 2.9 times above those in the healthy rats.
The eﬀect of ibuprofen treatment was similar to that of the
800 mg kg−1 dose of yerba mate. Panel D, finally, also confirms
the action of arthritis on the protein thiol levels in the plasma,
which consists in a pronounced diminution.18 Here, the action
of the yerba mate treatment was clearly eﬀective, with a clear
tendency toward normalization, at least in terms of statistical
significance. Both doses, however, had the same eﬀect, which
was similar to that of the ibuprofen treatment.
Another set of observations concerning plasma indicators
for arthritis and the response to the yerba mate treatment are
listed in Table 2. Yerba mate treatment of healthy rats did not
aﬀect any of the parameters listed in Table 2, albumin, globu-
lin and total protein levels and the AST and ALT activities. The
decreased albumin level in the arthritic rats confirms a pre-
vious observation, the same being true for the increased globu-
lin level.10 The yerba mate treatment preserved partially the
normal levels of both albumin and globulins, the same apply-
ing evidently to the albumin/globulin ratio. Both doses, 400
and 800 mg kg−1, acted similarly. The ibuprofen treatment was
equally eﬀective. There was also a strong tendency toward
higher AST levels in the arthritic rats, a phenomenon that pre-
sents considerable variations among diﬀerent studies.10,30 In
principle, the tendency is for a normalization by the yerba
mate treatment and by the ibuprofen treatment.
Brain and liver GSH and GSSG contents
The important components of the cellular oxidative homeosta-
sis, GSH and GSSG, were investigated in both the liver and
brain, and the results are shown in Fig. 3. In addition to the
tissue contents of both GSH and GSSG, the GSH/GSSG ratio
for each tissue is also shown taking into account its impor-
tance as an indicator of the oxidative status. Treatment of
healthy rats with 800 mg kg−1 yerba mate extract increased the
GSH content in the liver (panel A). Associated with a small ten-
dency toward smaller levels of GSSG (panel C), a relatively pro-
nounced increase in the GSH/GSSG ratio (panel E) caused by
both treatments was found in the liver (63% for the 400 mg
kg−1 dose and 73% for the 800 mg kg−1 dose). There was also
a tendency in this direction in the brain, however, without stat-
istical significance (panel F). Corroborating previous obser-
vations, arthritis decreased the GSH levels and raised the
GSSG levels in both the liver and brain leading to a pro-
nounced decrease in the GSH/GSSG ratios in both tissues.10,12
In the liver, the treatment with both doses of yerba mate
almost totally prevented these changes (panels A, C, E). The
ibuprofen treatment was almost equally eﬀective in this
respect. In the brain, the yerba mate had similar eﬀects, but
the lower dose (400 mg kg−1) tended to be less eﬀective than
the higher one (800 mg kg−1). Remarkably, in the brain, the
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ibuprofen treatment was poorly eﬀective in preventing the
decrease in the GSH/GSSG ratio (panel F).
Brain and liver enzyme activities linked to the oxidative state
The eﬀects of arthritis and the yerba mate treatment on the
activities of the enzymes involved in the interconversion of
GSH/GSSG are shown in Fig. 4. In the healthy rats, yerba mate
had no significant eﬀects on either glutathione reductase
(panels A and B) or glutathione peroxidase activities (panels C
and D) in both tissues, liver and brain. Arthritis, however,
diminished the activities of both enzymes in the liver and
brain, confirming previous observations.10,12 Treatment with
Fig. 1 Eﬀects of the aqueous extract of yerba mate treatment on oxidative stress indicators in the liver and brain. Legends: C, controls; C-T 400,
controls treated with 400 mg kg−1 yerba mate extract; C-T 800, controls treated with 800 mg kg−1; AIA, adjuvant-induced arthritic rats; AIA-T 400,
arthritic rats treated with 400 mg kg−1; AIA-T 800, arthritic rats treated with 800 mg kg−1; AIA-ibuprofen, arthritic rats treated with 35 mg kg−1 ibu-
profen. The data represent the mean ± SEM of 6 (healthy) or 7 (arthritic) rats. Columns with the same letters do not diﬀer statistically from each
other (p ≤ 0.05) according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing.
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yerba mate extracts almost totally prevented the decrease in
the glutathione reductase activities in both the liver and brain
(panels A and B). Both doses were equally eﬃcient. Ibuprofen
treatment had the same eﬀect. In the brain, the yerba mate
and ibuprofen treatments also prevented the decrease in the
glutathione peroxidase activity (panel D). In the liver, however,
no such prevention was found, the small tendency toward nor-
mality lacking statistical significance for both yerba mate and
ibuprofen (panel C).
The activities of three more enzymes, important for the oxi-
dative status of the liver and brain, namely catalase, superoxide
dismutase and xanthine oxidase, are shown in Fig. 5. The
activities of none of these enzymes were aﬀected by the yerba
mate treatment of the healthy rats. The very pronounced
decrease in the hepatic catalase activity caused by arthritis was
not prevented at all by either yerba mate or ibuprofen adminis-
tration (panel A).10 The much smaller decrease in the brain,12
however, was prevented by the yerba mate treatment, but not
by the ibuprofen treatment (panel B). The diminutions of the
superoxide dismutase activities of the liver and brain caused
by arthritis (panels C and D) were prevented at least by the
higher yerba mate dose (800 mg kg−1), an action that was
shared by the ibuprofen treatment (panels C and D). Xanthine
oxidase, finally, was increased by arthritis in both tissues
(panels E and F), confirming previous knowledge at least for
the brain.12 Treatment with the yerba mate extracts prevented
these modifications, the eﬀect being somewhat more pro-
nounced in the liver. Both doses were equally eﬀective in each
tissue. Ibuprofen also prevented the full increase in the activity
of xanthine oxidase in both tissues.
Inflammatory indicators
Three inflammatory indicators, usually prominent in the adju-
vant-induced arthritic rat, were investigated for the influence
of the yerba mate treatment: (a) paw edema, (b) secondary
lesions and (c) number of leukocytes recruited in the femoroti-
bial joint cavities. Fig. 6A and B show the time courses of the
increases in paw volume, a direct indication of the inflamma-
tory response that follows Freund’s adjuvant injection. As
Fig. 2 Eﬀects of the aqueous extract of yerba mate treatment on oxidative stress and inﬂammation indicators in plasma. Legends: C, controls; C-T
400, controls treated with 400 mg kg−1 yerba mate extract; C-T 800, controls treated with 800 mg kg−1; AIA, adjuvant-induced arthritic rats; AIA-T
400, arthritic rats treated with 400 mg kg−1; AIA-T 800, arthritic rats treated with 800 mg kg−1; AIA-ibuprofen, arthritic rats treated with 35 mg kg−1
ibuprofen. The data represent the mean ± SEM of 6 (healthy) or 7 (arthritic) rats. Columns with the same letters do not diﬀer statistically from each
other (p ≤ 0.05) according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing.
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expected, the injected paw responded faster (panel A) than the
non-injected paw (panel B).18 Treatment with the yerba mate
extract or ibuprofen of rats not injected with Freund’s adjuvant
had no influence on the paw volumes of the rats. Treatment
with yerba mate extracts or ibuprofen of rats injected with the
Freund’s adjuvant, on the other hand, had a diminishing
eﬀect on the development of the edema.
Fig. 6C shows the evaluation of the secondary lesion score
in the ears, front legs and tail, according to the standardized
protocol described in the Materials and methods section. The
severity of the injury was graded from zero to 5, with zero indi-
cating no injury. All treatments, lower and higher doses of
yerba mate extract and ibuprofen, delayed the appearance of
the secondary lesions equally. The diﬀerence between the
treated and non-treated rats, however, diminished continu-
ously in the period between days 11 and 17.
Data on the recruitment of leukocytes into the femorotibial
joint cavities in consequence of arthritis are shown in Table 3.
Confirming previous observations, the numbers of both mono-
nuclear and polymorphonuclear leukocytes in the right and
left knees were enormously increased by arthritis.18 The treat-
ment of the arthritic rats with the yerba mate extract caused
further increases in the number of mononuclear leukocytes in
both the left and right femorotibial joint cavities. This eﬀect
was not observed upon the ibuprofen treatment. The number
of polymorphonuclear leukocytes, on the other hand, was
diminished by the treatment with the yerba mate extract. This
eﬀect was dose-dependent, the higher dose being more
eﬀective. The ibuprofen treatment, however, in which the 35 mg
kg−1 dose was used, was considerably more eﬃcient in reducing
the number of infiltrated polymorphonuclear leukocytes.
Discussion
The experimental model used in this study is characterized by
a widespread inflammatory response. It can, thus, be con-
sidered a severe arthritis model in rats.9 The general outcome
of this study can be summarized as a positive demonstration
that the yerba mate extract used in this study can diminish
both the oxidative stress induced by adjuvant-induced arthritis
and several of the inflammatory events that characterize the
disease. We used two doses of the yerba mate extract, 400 and
800 mg kg−1, which correspond to the polyphenolics doses
listed in Table 1. In terms of chlorogenic acids this corres-
ponds to daily doses of 14.29 and 28.57 mg kg−1, respectively.
It has been estimated that consumers of the traditional bever-
age chimarrão may ingest daily up to 1 g of chlorogenic
acids.31 For an individual weighing 75 kg, this would corres-
pond to a dose of 13.4 mg kg−1. The smaller dose of extract
given to the rats in our experiments is, thus, close to the yerba
mate ingestion by consumers of the traditional beverage
chimarrão. This is a dose for which no significant toxicological
manifestations have ever been communicated, a fact that was
corroborated, among others, by data of a previous investi-
gation of our group.5Ta
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The yerba mate extract showed at least some degree of
action on most indicators of oxidative stress caused by adju-
vant-induced arthritis that were monitored in the present
study: (a) it diminished the ROS levels in the liver and brain;
(b) it decreased the oxidative protein and lipid damage in the
liver and brain; (c) it increased the antioxidant capacity in the
plasma as indicated by the FRAP assay, the thiol levels and the
albumin levels; (d) it increased the GSH levels and the GSH/
GSSH ratio in both the liver and brain; (e) it almost restored
the activities of both enzymes directly linked to the metab-
olism of GSH–GSSH, glutathione reductase and glutathione
peroxidase, in the brain; (f ) it almost restored the activity of
Fig. 3 Eﬀects of the aqueous extract of yerba mate treatment on GSH and GSSG levels in the liver and brain. Legends: C, controls; C-T 400, con-
trols treated with 400 mg kg−1 yerba mate extract; C-T 800, controls treated with 800 mg kg−1; AIA, adjuvant-induced arthritic rats; AIA-T 400,
arthritic rats treated with 400 mg kg−1; AIA-T 800, arthritic rats treated with 800 mg kg−1; AIA-ibuprofen, arthritic rats treated with 35 mg kg−1 ibu-
profen. The data represent the mean ± SEM of 6 (healthy) or 7 (arthritic) rats. Columns with the same letters do not diﬀer statistically from each
other (p ≤ 0.05) according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing.
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glutathione reductase in the liver, but failed in doing the same
with glutathione peroxidase; (g) it also reversed the modified
activities of xanthine oxidase and superoxide dismutase in
both the liver and brain, whereas a similar action on catalase
was found only in the brain. Remarkably, however, the well-
known anti-inflammatory agent ibuprofen (35 mg kg−1), whose
action was monitored in parallel experiments, exerted similar
eﬀects on most variables measured. The exceptions can be
named in short: contrary to the yerba mate extract, ibuprofen
did not normalize the CAT activity in the brain of the arthritic
rats nor did it restore the SOD activity in the same tissue.
Conversely, with respect to the most typical indicators of
inflammation, which one expects to be attenuated by ibupro-
fen, the yerba mate extract had a similar action, although
somewhat less pronounced in some cases. The actions of both
doses of the yerba mate extract (400 and 800 mg kg−1) and ibu-
profen on the edematous paw volume increases cannot be dis-
tinguished from each other, the same being valid for the delay
in the development of the secondary lesions resulting from
arthritis. The diminution of the highly augmented levels of the
plasma myeloperoxidase activity caused by ibuprofen was also
not significantly diﬀerent from the decrease caused by the
highest yerba mate dose. Only in the case of the polymorpho-
nuclear leucocytes infiltrations in the femorotibial joint cav-
ities was there a diﬀerence between the action of the highest
yerba mate dose and ibuprofen, the latter being more eﬀective.
The decrease caused by yerba mate in the number of leuko-
cytes recruited into the inflammatory site was already
suggested for several inflammation models based on the dim-
inution of the local myeloperoxidase activity.14,15
Ilex paraguariensis extracts have been reported to scavenge
very eﬀectively DPPH, ABTS, peroxyl radicals and ROS gener-
ated by isolated mitochondria and to reduce products formed
during lipid peroxidation.5 Ibuprofen, however, is basically a
non-steroidal anti-inflammatory, whose direct antioxidant
action has been reported to be very weak. As other non-ster-
oidal anti-inflammatories, ibuprofen has been found to act as
a free-radical scavenger at concentrations around or well above
Fig. 4 Eﬀects of the aqueous extract of yerba mate treatment on enzyme activities linked to GSH/GSSG metabolism in the liver and brain. Legends:
C, controls; C-T 400, controls treated with 400 mg kg−1 yerba mate extract; C-T 800, controls treated with 800 mg kg−1; AIA, adjuvant-induced
arthritic rats; AIA-T 400, arthritic rats treated with 400 mg kg−1; AIA-T 800, arthritic rats treated with 800 mg kg−1; AIA-ibuprofen, arthritic rats
treated with 35 mg kg−1 ibuprofen. The data represent the mean ± SEM of 6 (healthy) or 7 (arthritic) rats. Columns with the same letters do not diﬀer
statistically from each other (p ≤ 0.05) according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing.
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1 mM, which can be considered highly improbable for in vivo
conditions.32,33 For this reason, its eﬀects against oxidative
stress in vivo or in isolated cell systems are most probably
resulting from its anti-inflammatory action. Consequently, the
similar actions listed in the preceding paragraph for the yerba
mate extract and ibuprofen on the symptoms of arthritis raise
the question if, after all, the main action of the yerba mate
extract is much more linked to its anti-inflammatory action
than to its antioxidant activity. Actually, anti-inflammatory
activity in several experimental models has been frequently
demonstrated for several components of yerba mate. The
group of compounds sometimes referred collectively as caﬀeic
acid derivatives (salvianolic acid I and chlorogenic acids,
especially 3-O-caﬀeoylquinic, 4-O-caﬀeoylquinic, 5-O-caﬀeoyl-
quinic, 3,5-O-dicaﬀeoylquinic acids, etc.), for example, are
quite abundant in yerba mate (see Table 1).5 It should be men-
Fig. 5 Eﬀects of the aqueous extract of yerba mate treatment on enzyme activities linked to the oxidative status of the liver and brain. Legends: C,
controls; C-T 400, controls treated with 400 mg kg−1 yerba mate extract; C-T 800, controls treated with 800 mg kg−1; AIA, adjuvant-induced
arthritic rats; AIA-T 400, arthritic rats treated with 400 mg kg−1; AIA-T 800, arthritic rats treated with 800 mg kg−1; AIA-ibuprofen, arthritic rats
treated with 35 mg kg−1 ibuprofen. The data represent the mean ± SEM of 6 (healthy) or 7 (arthritic) rats. Columns with the same letters do not diﬀer
statistically from each other (p ≤ 0.05) according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing.
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tioned, however, that all these compounds are rapidly trans-
formed in vivo. It has been shown, for example, that hydrolysis
of chlorogenic acids by esterases occurs rapidly after oral
administration to both rats and humans so that the peak
plasma concentrations of these compounds are considerably
lower than the peak plasma concentrations of their transform-
ation products.6,7 The latter are mainly caﬀeic and ferulic
acids. For these compounds, however, anti-oxidant activities
have also been demonstrated, so that it is likely that a con-
siderable part of the antioxidant action observed in the
present work is actually exerted by metabolites of the chloro-
genic acids rather than by the parent compounds
themselves.34–36 Besides their antioxidant actions, both chloro-
genic acids and their metabolites also exert anti-inflammatory
activity as demonstrated in several models, including rheuma-
toid arthritis.34–37 It was found, for example, that oral adminis-
tration of 40 mg kg−1 of 5-O-caﬀeoylquinic acid (chlorogenic
acid) eﬀectively suppressed the pro-inflammatory cytokines
TNFα and IL-1β in a lipopolysaccharide-induced arthritis
model in rats.38 In line with our findings is the observation
that a similar treatment with ibuprofen produced similar
eﬀects. Furthermore, I. paraguariensis extracts inhibit the
activity of pro-inflammatory enzymes such as cyclooxygenase-2
and the inducible nitric oxide synthase.15 These eﬀects have
also been demonstrated for pure chlorogenic acid.39 Moreover,
treatment with yerba mate decreases the levels of adenosine
deaminase (ADA), which, in turn, could mean a diminution of
neutrophil degranulation and its oxidant activity.14 The
decrease in neutrophil activation may also be related to
plasma myeloperoxidase levels, considering that the enzyme is
present in the azurophilic granules of neutrophils and released
when these cells are activated.14
All these observations mentioned in the preceding para-
graph and several others to be found in the literature confirm,
thus, the importance of the anti-inflammatory actions of yerba
mate, mediated by salvianolic acid I (a caﬀeic acid trimer),
chlorogenic acids (especially 3-O-caﬀeoylquinic, 4-O-caﬀeoyl-
quinic, 5-O-caﬀeoylquinic and 3,5-O-dicaﬀeoylquinic acids)
and probably by their metabolites caﬀeic and ferulic acids,
which could be largely responsible also for its anti-oxidant
action. Analysis of the total administered amount of these
compounds, displayed in Table 1, reveals that they are within
the same range as the dose of ibuprofen that was administered
and that produced similar eﬀects. On the other hand, direct
Fig. 6 Inﬂuence of the aqueous extract of yerba mate treatment on the development of the inﬂammatory response to the Freund’s adjuvant injec-
tion. Legends: C, controls; C-T 400, controls treated with 400 mg kg−1 yerba mate extract; C-T 800, controls treated with 800 mg kg−1; AIA, adju-
vant-induced arthritic rats; AIA-T 400, arthritic rats treated with 400 mg kg−1; AIA-T 800, arthritic rats treated with 800 mg kg−1; AIA-ibuprofen,
arthritic rats treated with 35 mg kg−1 ibuprofen. The data represent the mean ± SEM of 6 (healthy) or 7 (arthritic) rats. Asterisks (*) indicate signiﬁcant
diﬀerences between the AIA group and all others (p ≤ 0.05), and dashes (#) indicate signiﬁcant diﬀerences between the AIA group and AIA-ibupro-
fen group according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing.
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free radical scavenging by components of yerba mate is a well-
established phenomenon4,5 and it is likely that this property
equally contributed in some way to the overall eﬀect of the
extract used in the present work. It is generally accepted that
ROS, initially produced in consequence of the inflammatory
events, can additionally increase the inflammatory response by
eﬀecting NF-kB signaling, modulating proximal events in
(TLR)-4 signaling.40 Inflammation and ROS production are,
thus, interdependent phenomena capable of mutually influen-
cing each other. ROS scavenging by the yerba mate extract
compounds, therefore, could be equally active in reducing the
inflammatory response. Improvement in inflammation via
TLR4/MyD88/NF-κB has indeed been shown to occur in spinal
cord injured rats by treatment with chlorogenic acid.38
A direct action on the antioxidant defenses by components
of the yerba mate extract is also suggested by the eﬀects of the
GSH levels and the GSH/GSSG redox ratio. We found in this
work that the yerba mate treatment increased both variables in
the liver of the healthy rats. Similar observations were also
done in healthy humans in which the yerba mate treatment
improved the GSH levels and promoted a significant enhance-
ment in the catalase (28.7%), superoxide dismutase (21.3%),
and glutathione peroxidase (9.6%) activities.41
There is an interesting parallel that can be traced between
Ilex paraguariensis (yerba mate) and Camellia sinensis
(especially green tea).42 Both have been used traditionally for
the preparation of stimulant beverages, originally in two
diﬀerent continents, Asia and South America. Camellia sinensis
has since long gained an almost universal distribution and
acceptance, whereas this process is presently at its beginnings
for Ilex paraguariensis. However, to both species eﬀects against
several health disorders have been attributed in addition to
the stimulating actions exerted by their methylxanthine con-
stituents (caﬀeine, theobromine and theophylline). The
common list includes antidiabetic actions, cancer prevention,
antioxidant properties and anti-inflammatory eﬀects.
Unsurprisingly, the results obtained in the present study with
Ilex paraguariensis are very similar to the results obtained in a
previous study of our group with Camellia sinensis (green
tea).43 The green tea extract improved the oxidative state of the
adjuvant-induced arthritic rats by aﬀecting practically the
same parameters in the liver, brain and plasma as the yerba
mate extract: diminution of ROS contents, diminution of
damage to proteins and lipids and increases in the anti-
oxidant defenses.43 There are also studies indicating anti-
inflammatory actions for green tea and green tea
components.44,45 These and other similarities certainly
reinforce the parallelism of both species as medicinal plants
worldwide. However, it is equally important to note that their
most important bioactive compounds are not the same. In
Camellia sinensis catechin and catechin derivatives such as
(−)-epigallocatechin-3-gallate (EGCG), epigallocatechin (EGC)
and epicatechin-3-gallate (ECG) are considered to be the most
important active molecules,44 whereas in Ilex paraguariensis
the group of compounds frequently referred collectively as
caﬀeic acid derivatives, especially salvianolic acid I (a caﬀeic
acid trimer) and chlorogenic acids (mainly 3-O-caﬀeoylquinic,
4-O-caﬀeoylquinic, 5-O-caﬀeoylquinic, and 3,5-O-caﬀeoylquinic
acids (see Table 1)) are likely to be responsible for a significant
part of the eﬀects.
Conclusion
In conclusion, yerba mate administration was beneficial to the
adjuvant-induced arthritic rats by diminishing both inflam-
mation and oxidative stress. The latter means also a substan-
tial reduction in the injury to lipids and proteins caused by the
disease. It is possible that the anti-inflammatory actions of
yerba mate constituents are the primary events producing
those beneficial eﬀects. Direct ROS scavenging, however, may
also play a significant role since inflammation and ROS pro-
duction are interdependent phenomena capable of mutually
influencing each other. In principle, the same can be expected
for patients suﬀering from rheumatoid arthritis if one takes
into account the similarities between the latter pathological
manifestation and the adjuvant-induced disease in rats. One
can also expect that the continued daily ingestion of the tra-
ditional yerba mate beverages (e.g., in the form of chimarrão
in Brazil), a common practice of millions of people in the
southern cone of South America, may be eﬀective in attenuat-
ing the symptoms of inflammatory diseases, especially in
older adults.
Table 3 Eﬀects of the yerba mate extract and ibuprofen treatments on the mononuclear and polymorphonuclear leukocyte counts in the right and
left femorotibial joint cavities of the adjuvant-induced arthritic rats. The data represent the mean ± SEM. Values labeled in the same column with the
same letter do not diﬀer statistically from each other (p < 0.05) according to one-way ANOVA followed by Student–Newman–Keuls post hoc testing
Groups
Right femorotibial joint cavity Left femorotibial joint cavity
Mononuclear
leukocytes
Polymorphonuclear
leukocytes
Mononuclear
leukocytes
Polymorphonuclear
leukocytes
Control 2.43 ± 0.05a 0.57 ± 0.05a 2.08 ± 0.03a 0.48 ± 0.03a
Arthritic 58.82 ± 3.36b 173.15 ± 3.89b 86.41 ± 4.35b 334.79 ± 8.49b
Treated arthritic (400 mg kg−1) 77.68 ± 3.81c 110.52 ± 2.68c 123.13 ± 4.98c 197.51 ± 2.72c
Treated arthritic (800 mg kg−1) 75.69 ± 2.74c 72.57 ± 1.82d 106.23 ± 2.91d 137.74 ± 4.17d
Ibuprofen (35 mg kg−1) 67.52 ± 2.62b,c 38.88 ± 3.01e 93.17 ± 2.52b 61.10 ± 2.47e
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